Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline

Apr 5

Written By Yiran Gan

2020.11.02

SY Yang, HC Liu and WP Chen

Neurol Therapy (2020)

https://link.springer.com/article/10.1007/s40120-020-00215-2

Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction

Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model